Bayer Stroke Drug Meets Trial Goal After First Hitting Roadblock
Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage clinical study, a boost for the German company as it seeks to counter sales declines from aging...
By Sonja Wind, Mark Schroers · Bloomberg
Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage clinical study, a boost for the German company as it seeks to counter sales declines from aging blockbuster medicines.